Heart disease and stroke statistics—2019 update: a report from the American Heart Association
Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …
Institutes of Health and other government agencies, brings together in a single document the …
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
The global burden of valvular heart disease: from clinical epidemiology to management
G Santangelo, F Bursi, A Faggiano… - Journal of clinical …, 2023 - mdpi.com
Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies
Kidney transplantation (KT) is the optimal therapy for end-stage kidney disease (ESKD),
resulting in significant improvement in survival as well as quality of life when compared with …
resulting in significant improvement in survival as well as quality of life when compared with …
[HTML][HTML] Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Chronic kidney disease (CKD) is a major risk factor for valvular heart disease (VHD). Mitral
annular and aortic valve calcifications are highly prevalent in CKD patients and commonly …
annular and aortic valve calcifications are highly prevalent in CKD patients and commonly …
Kidney dysfunction and the risk of develo** aortic stenosis
Background Chronic kidney disease (CKD) and aortic stenosis (AS) share many risk factors.
Objectives This study sought to evaluate whether kidney dysfunction is associated with the …
Objectives This study sought to evaluate whether kidney dysfunction is associated with the …
Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association
Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …
Cardiovascular complications of chronic kidney disease: an introduction
H Warrens, D Banerjee… - European Cardiology …, 2022 - pmc.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the primary cause of morbidity and mortality in chronic
kidney disease (CKD). CVD mortality risk doubles and triples in CKD stages 3 and 4 …
kidney disease (CKD). CVD mortality risk doubles and triples in CKD stages 3 and 4 …